Feed TTOO
TT

T2 Biosystems, Inc.

TTOO · OTC

$0.00 +0.00% (+$0.00)
1M -80.00%
Market Cap $16.8K
P/E Ratio -
Div. Yield -
ROE -
Piotroski F-Score Weak
3/9
Valuation
100 /100
Cheap
P/S 0.00x
EV/FFO N/A
P/E N/A
Growth
0 /100
Declining
Rev. growth 26.52%
Book val. growth N/A
EPS growth N/A
Profitability
0 /100
Weak
Op. margin 690.45%
Gross margin 113.58%
FCF margin 671.88%
Quality
4 /100
Poor
Asset turnover 0.21x
ROIC 230.51%
ROA 143.91%
Debt
1 /100
High
Int. coverage -8.37x
Current ratio 0.45x
Debt/Assets N/A
Stability
14 /100
Unstable
EPS volatility 45.06%
Beta 7.95x
Profitable years 0

Bulios Scoring descrie calitatea și istoricul unei companii, nu randamentul viitor. Un scor ridicat nu este un semnal de cumpărare. Află mai multe

Întreabă StockBot despre TTOO
Online

Despre companie

T2 Biosystems, Inc. is an American biotechnology company that specializes in the diagnosis of infectious diseases. It utilizes a technology called T2 Magnetic Resonance (T2MR), which combines magnetic resonance with nanoparticles for the detection of pathogens in biological samples. T2 Biosystems focuses on innovative diagnostic solutions aimed at accelerating the process of infection diagnosis and improving patient care. Shares of T2 Biosystems, Inc. are traded on the stock exchange and may be an interesting investment opportunity for those following developments in biotechnology and diagnostics.

Nu este încă disponibil în limba dumneavoastră, așa că textul este în engleză.

Sector

Healthcare

Industry

Medical - Diagnostics & Research

CEO

Craig R. Jalbert

Employees

113

Headquarters

Lexington

Evenimente viitoare

13 NOV.

Earnings

Upcoming earnings report

52d

Folosim cookie-uri esențiale pentru funcționarea site-ului și cookie-uri analitice opționale pentru a măsura utilizarea. Consultați Politica de confidențialitate.